Theranostic Nanomedicines for the Treatment of Cardiovascular and Related Diseases: Current Strategies and Future Perspectives

Theranostic Nanomedicines for the Treatment of Cardiovascular and Related Diseases: Current Strategies and Future Perspectives

Cardiovascular and related diseases (CVRDs) are among the most prevalent chronic diseases in the 21st century, with a high mortality rate. This review summarizes the various nanomedicines for diagnostic and therapeutic applications in CVRDs, including nanomedicine for angina pectoris, myocarditis, m...

Full description

Bibliographic Details
Main Authors:	Natasha Manners, Vishnu Priya, Abhishesh Kumar Mehata, Manoj Rawat, Syam Mohan, Hafiz A. Makeen, Mohammed Albratty, Ali Albarrati, Abdulkarim M. Meraya, Madaswamy S. Muthu
Format:	Article
Language:	English
Published:	MDPI AG 2022-04-01
Series:	Pharmaceuticals
Subjects:	atherosclerosis cardiovascular disease personalized therapy pharmaceutical nanomedicine targeted delivery
Online Access:	https://www.mdpi.com/1424-8247/15/4/441

Similar Items

Vitamin E TPGS-Based Nanomedicine, Nanotheranostics, and Targeted Drug Delivery: Past, Present, and Future
by: Abhishesh Kumar Mehata, et al.
Published: (2023-02-01)

Biomimetic nanomedicines for precise atherosclerosis theranostics
by: Ying Tao, et al.
Published: (2023-11-01)

Nanomedicine: Principles, Properties, and Regulatory Issues
by: Sara Soares, et al.
Published: (2018-08-01)

Nanomedicine for Diagnosis and Treatment of Atherosclerosis
by: Jingyun Cheng, et al.
Published: (2023-12-01)

Immunomodulatory Nanomedicine for the Treatment of Atherosclerosis
by: Linsey J. F. Peters, et al.
Published: (2021-07-01)

Advanced Peptide Nanomedicines for Bladder Cancer Theranostics
by: Sheng Zeng, et al.
Published: (2022-08-01)

Development of Pharmaceutical Nanomedicines: From the Bench to the Market
by: Abdulrahman A. Halwani
Published: (2022-01-01)

Macrophage-targeted nanomedicine for the diagnosis and management of atherosclerosis
by: Ping Ping Hu, et al.
Published: (2022-09-01)

Mesoporous Silica Nanoparticles as Theranostic Antitumoral Nanomedicines
by: Alejandro Baeza, et al.
Published: (2020-10-01)

Nanomedicine and Drug Delivery Strategies for Theranostics Applications
by: Ermakov, Alexey Vadimovich, et al.
Published: (2020-06-01)

Multifunctional theranostic nanomedicines for cancer treatment: Recent progress and challenges
by: Laxmanan Karthikeyan, et al.
Published: (2023-06-01)

Bioimaging guided pharmaceutical evaluations of nanomedicines for clinical translations
by: Ruslan G. Tuguntaev, et al.
Published: (2022-05-01)

Advances on Nanomedicines for Diagnosis and Theranostics of Hepatic Fibrosis
by: Xinghang Dai, et al.
Published: (2021-07-01)

Recent Progress in the Theranostics Application of Nanomedicine in Lung Cancer
by: Anubhab Mukherjee, et al.
Published: (2019-04-01)

Industrialization’s eye view on theranostic nanomedicine
by: Maharajan Sivasubramanian, et al.
Published: (2022-08-01)

Nanomaterials as Promising Theranostic Tools in Nanomedicine and Their Applications in Clinical Disease Diagnosis and Treatment
by: Wei Zhu, et al.
Published: (2021-12-01)

Nanomedicine /
by: Hutto, Madelynn, author 647998
Published: (2012)

Combating atherosclerosis with targeted nanomedicines: recent advances and future prospective
by: Ailar Nakhlband, et al.
Published: (2018-01-01)

Theranostics Nanomedicine Applications for Colorectal Cancer and Metastasis: Recent Advances
by: Phanindra Babu Kasi, et al.
Published: (2023-04-01)

Recent Progress in Nanomedicine for Melanoma Theranostics With Emphasis on Combination Therapy
by: Mengqi Guan, et al.
Published: (2021-03-01)

Bioresponsive Nanomedicine: The Next Step of Deadliest Cancers' Theranostics
by: Yuqiang Mao, et al.
Published: (2020-04-01)

Theranostic nanoplatform to target macrophages enables the inhibition of atherosclerosis progression and fluorescence imaging of plaque in ApoE(−/−) mice
by: Qi Wang, et al.
Published: (2021-07-01)

Hyaluronic Acid-Based Theranostic Nanomedicines for Targeted Cancer Therapy
by: So Yun Lee, et al.
Published: (2020-04-01)

Theranostic applications of selenium nanomedicines against lung cancer
by: Shaowei Liu, et al.
Published: (2023-03-01)

Current Nanomedicine for Targeted Vascular Disease Treatment: Trends and Perspectives
by: Kyung-A Choi, et al.
Published: (2022-10-01)

Editorial: Novel approaches aiming to overcome current nanomedicine limitations
by: Roberto Palomba, et al.
Published: (2023-07-01)

Anti-inflammation nanomedicine shots through atherosclerotic plaques for targeted treatment and precise diagnosis
by: Liyun Zhu, et al.
Published: (2023-07-01)

The clinical nanomedicine handbook /
by: Brenner, Sara, 1980- editor
Published: (2014)

Nanomedicine and Laser Medicine /
by: Wolford, Marianela, author 647997, et al.
Published: (2012)

Current status and vision of local pharmaceutical industries in Saudi Arabia: The focus on nanomedicines
by: Abdulrahman A. Halwani, et al.
Published: (2023-08-01)

D-ɑ-tocopheryl polyethylene glycol succinate: A review of multifarious applications in nanomedicines
by: Popat S. Kumbhar, et al.
Published: (2022-03-01)

Nanomedicine-based drug delivery strategies for the treatment of atherosclerosis
by: Yongfang Lin, et al.
Published: (2024-06-01)

Recent Progress in Nanomaterial-Based Biosensors and Theranostic Nanomedicine for Bladder Cancer
by: Fan-Xin Song, et al.
Published: (2023-01-01)

Nanomedicine in Diagnostics /
by: Rozlosnik, Noemi, editor 551496
Published: (2012)

Polymers in nanomedicine /
by: Kunugi, Shigeru, et al.
Published: (c201)

The handbook of nanomedicine /
by: Jain, K. K. (Kewal K.)
Published: (2008)

Functional polymers for nanomedicine resource /
by: Shen, Youqing 543999
Published: (2013)

Nanomedicine and regulatory science: the challenges in Africa
by: N. Z. Nyazema, et al.
Published: (2023-11-01)

Programming assembly of biomimetic exosomes: An emerging theranostic nanomedicine platform
by: Xiao Xu, et al.
Published: (2023-10-01)

Design of theranostic nanomedicine (II): synthesis and physicochemical properties of a biocompatible polyphosphazene–docetaxel conjugate
by: Jun YJ, et al.
Published: (2017-07-01)